XGN logo

Exagen (XGN) EBIT

Annual EBIT

-$21.32 M
+$23.90 M+52.85%

December 31, 2023

Summary

Performance

1-Year Change

+52.85%

3-Year Change

-50.14%

5-Year Change

-319.21%

15-Year Change

+8.23%

XGN EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

54.1%
XGN annual earnings before interest & taxes is higher than 54.1% of companies in Healthcare sector

High & Low

All-time High

-$5.09 M

3-Year Low

-$45.22 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
XGN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 18, 2025
XGN next annual earnings announcement is scheduled for Mar 18, 2025

OtherXGNprofitabilitymetrics:

Annual Revenue

$52.55 M
XGN annual revenue is $52.55 million

Annual Net Income

-$23.69 M
XGN annual net profit is -$23.69 million

Annual EBITDA

-$19.15 M
XGN annual EBITDA is -$19.15 million

Annual EPS

-$1.34
XGN annual earnings per share is -$1.34

Quarterly EBIT

-$4.47 M
-$2.06 M-85.62%

September 30, 2024

Summary

Performance

3-Month Change

-85.62%

1-Year Change

+8.07%

3-Year Change

+31.3%

5-Year Change

-21.99%

XGN Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.88%
XGN quarterly earnings before interest & taxes is higher than 52.88% of companies in Healthcare sector

High & Low

All-time High

-$489.00 K

3-Year Low

-$14.06 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
XGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
XGN next earnings announcement is scheduled for Mar 18, 2025

OtherXGNprofitabilitymetrics:

Quarterly Revenue

$12.51 M
XGN quarterly revenue is $12.51 million

Quarterly Net Income

-$5.03 M
XGN quarterly net profit is -$5.03 million

Quarterly EBITDA

-$4.47 M
XGN quarterly EBITDA is -$4.47 million

Quarterly EPS

-$0.28
XGN quarterly earnings per share is -$0.28

TTM EBIT

-$14.66 M
+$392.00 K+2.60%

September 30, 2024

Summary

Performance

3-Month Change

+2.6%

1-Year Change

+51.72%

3-Year Change

+28.76%

5-Year Change

-4.31%

XGN TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

59.15%
XGN TTM earnings before interest & taxes is higher than 59.15% of companies in Healthcare sector

High & Low

All-time High

-$1.05 M

3-Year Low

-$45.22 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
XGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
XGN next earnings announcement is scheduled for Mar 18, 2025

OtherXGNprofitabilitymetrics:

TTM Revenue

$55.75 M
XGN TTM revenue is $55.75 million

TTM Net Income

-$16.93 M
XGN TTM net profit is -$16.93 million

TTM EBITDA

-$13.26 M
XGN TTM EBITDA is -$13.26 million

TTM EPS

-$0.94
XGN TTM earnings per share is -$0.94

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$21.32 M
XGN annual earnings before interest & taxes is -$21.32 million

Annual Revenue

$52.55 M
XGN annual revenue is $52.55 million

Annual Cost Of Goods Sold

$23.09 M
XGN annual cost of goods sold is $23.09 million

Annual Operating Expenses

$52.29 M
XGN annual total operating expenses is $52.29 million

XGN EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+52.9%+8.1%+51.7%
3 y3 years-50.1%+31.3%+28.8%
5 y5 years-319.2%-22.0%-4.3%

XGN EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+52.9%-85.6%+68.2%at high+67.6%
5 y5-year-150.2%+52.9%-85.6%+68.2%-72.0%+67.6%
alltimeall time-319.2%+52.9%-813.3%+68.2%-1293.3%+67.6%

Exagen EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.47 M(+85.6%)
-$14.66 M(-2.6%)
Jun 2024
-
-$2.41 M(-14.4%)
-$15.05 M(-11.9%)
Mar 2024
-
-$2.81 M(-43.5%)
-$17.08 M(-19.9%)
Dec 2023
-$21.32 M(-52.9%)
-$4.97 M(+2.4%)
-$21.32 M(-29.8%)
Sep 2023
-
-$4.86 M(+9.4%)
-$30.36 M(-7.9%)
Jun 2023
-
-$4.44 M(-37.0%)
-$32.98 M(-22.6%)
Mar 2023
-
-$7.05 M(-49.7%)
-$42.60 M(-5.8%)
Dec 2022
-$45.22 M(+88.0%)
-$14.01 M(+87.3%)
-$45.22 M(+20.8%)
Sep 2022
-
-$7.48 M(-46.8%)
-$37.45 M(+2.7%)
Jun 2022
-
-$14.06 M(+45.3%)
-$36.47 M(+29.5%)
Mar 2022
-
-$9.67 M(+55.1%)
-$28.16 M(+17.1%)
Dec 2021
-$24.05 M(+69.4%)
-$6.24 M(-4.0%)
-$24.05 M(+16.9%)
Sep 2021
-
-$6.50 M(+13.1%)
-$20.57 M(+16.0%)
Jun 2021
-
-$5.75 M(+3.3%)
-$17.73 M(+20.5%)
Mar 2021
-
-$5.56 M(+101.4%)
-$14.71 M(+3.6%)
Dec 2020
-$14.20 M
-$2.76 M(-24.6%)
-$14.20 M(+1.1%)
Sep 2020
-
-$3.66 M(+34.2%)
-$14.05 M(+11.3%)
Jun 2020
-
-$2.73 M(-46.0%)
-$12.62 M(+7.2%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$5.05 M(+93.3%)
-$11.77 M(+38.1%)
Dec 2019
-$8.52 M(+67.6%)
-$2.61 M(+17.0%)
-$8.52 M(+33.2%)
Sep 2019
-
-$2.23 M(+19.0%)
-$6.40 M(+22.6%)
Jun 2019
-
-$1.88 M(+4.0%)
-$5.22 M(+56.1%)
Mar 2019
-
-$1.80 M(+268.7%)
-$3.34 M(+117.0%)
Dec 2018
-$5.09 M(-78.1%)
-$489.00 K(-53.5%)
-$1.54 M(+46.5%)
Sep 2018
-
-$1.05 M(-30.9%)
-$1.05 M(-92.7%)
Dec 2017
-$23.23 M(+61.0%)
-
-
Dec 2015
-$14.43 M(+19.7%)
-$1.52 M(-25.0%)
-$14.43 M(-1.1%)
Sep 2015
-
-$2.03 M(-76.3%)
-$14.59 M(-11.7%)
Jun 2015
-
-$8.57 M(+271.9%)
-$16.52 M(+46.7%)
Mar 2015
-
-$2.31 M(+36.7%)
-$11.26 M(-6.6%)
Dec 2014
-$12.05 M(-3.7%)
-$1.69 M(-57.4%)
-$12.05 M(-26.7%)
Sep 2014
-
-$3.96 M(+19.4%)
-$16.45 M(+13.1%)
Jun 2014
-
-$3.31 M(+6.9%)
-$14.55 M(+29.5%)
Mar 2014
-
-$3.10 M(-49.1%)
-$11.23 M(+38.1%)
Dec 2013
-$12.51 M(+83.5%)
-$6.09 M(+197.4%)
-$8.13 M(+297.4%)
Sep 2013
-
-$2.05 M
-$2.05 M
Dec 2012
-$6.82 M
-
-

FAQ

  • What is Exagen annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Exagen?
  • What is Exagen annual EBIT year-on-year change?
  • What is Exagen quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Exagen?
  • What is Exagen quarterly EBIT year-on-year change?
  • What is Exagen TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Exagen?
  • What is Exagen TTM EBIT year-on-year change?

What is Exagen annual earnings before interest & taxes?

The current annual EBIT of XGN is -$21.32 M

What is the all time high annual EBIT for Exagen?

Exagen all-time high annual earnings before interest & taxes is -$5.09 M

What is Exagen annual EBIT year-on-year change?

Over the past year, XGN annual earnings before interest & taxes has changed by +$23.90 M (+52.85%)

What is Exagen quarterly earnings before interest & taxes?

The current quarterly EBIT of XGN is -$4.47 M

What is the all time high quarterly EBIT for Exagen?

Exagen all-time high quarterly earnings before interest & taxes is -$489.00 K

What is Exagen quarterly EBIT year-on-year change?

Over the past year, XGN quarterly earnings before interest & taxes has changed by +$392.00 K (+8.07%)

What is Exagen TTM earnings before interest & taxes?

The current TTM EBIT of XGN is -$14.66 M

What is the all time high TTM EBIT for Exagen?

Exagen all-time high TTM earnings before interest & taxes is -$1.05 M

What is Exagen TTM EBIT year-on-year change?

Over the past year, XGN TTM earnings before interest & taxes has changed by +$15.70 M (+51.72%)